SCHEMBL434952

SCHEMBL434952

O=[N+]([O-])c1ccc(N=C2C=CC3=C(C2)Sc2ccccc2N3)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SNCA P37840 4/20 0.48
▸ TTR P02766 2/20 0.44
▸ LRRK2 Q5S007 1/20 0.44
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ GGT1 P19440 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MARK4 Q96L34 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ BCHE P06276 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ NOX1 Q9Y5S8 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL563959 0.84 GAA (0.42) SNCALRRK2KMT2AMEN1RAB9A
SCHEMBL433232 0.82 NOX1 (0.42) SNCAKMT2AMEN1RAB9ANPC1
SCHEMBL436033 0.80 NOX1 (0.41) SNCAKMT2AMEN1RAB9ANPC1
SCHEMBL433635 0.79 MAPT (0.39) SNCAKMT2AMEN1RAB9ANPC1
SCHEMBL435356 0.79 NOX1 (0.35) SNCAKMT2AMEN1RAB9ANPC1
SCHEMBL434466 0.79 MAPT (0.46) SNCATTRLRRK2KMT2AMEN1
SCHEMBL434961 0.79 NOX1 (0.46) SNCAKMT2AMEN1RAB9ANPC1
SCHEMBL434444 0.77 NOX1 (0.36) SNCAKMT2AMEN1RAB9ANPC1
SCHEMBL433397 0.76 MAPT (0.41) SNCAKMT2AMEN1RAB9ANPC1
SCHEMBL432486 0.76 MEN1 (0.45) SNCALRRK2KMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11851685-B2 Zwitterion buffer containing compositions and uses in electroanalytical devices and methods ROCHE DIABETES CARE, INC. (US) 2023-12-26 — — US claimed
EP-1867732-A1 Reagents, methods and devices for detecting analytes Bayer Corporation (US) 2007-12-19 — — EP claimed
EP-1293574-B1 Reagents, methods and devices for detecting analytes BAYER CORP (US) 2007-11-21 — — EP claimed
US-7163616-B2 Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes BAYER CORPORATION (US) 2007-01-16 — — US claimed
US-20030094384-A1 Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2003-05-22 — — US claimed
EP-1293574-A2 Reagents, methods and devices for detecting analytes Bayer Corporation (US) 2003-03-19 — — EP claimed
EP-0747984-B1 Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof BAYER AG (US) 2002-08-14 — — EP claimed
EP-0747984-A2 Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof Bayer Corporation (US) 1996-12-11 — — EP claimed
US-5520786-A ELECTRODE SURFACE HAS BEEN IMPARTED BY A MEDIATOR FUNCTION COMPRISING ONE OR MORE MEDIATOR COMPOUNDS SELECTED FROM SUBSTITUTED OR UNSUBSTITUTED 3-PHENYLIMINO-3H-PHENOTHIAZINES AND 3-PHENYLIMINO-3H-PHENOXAZINES BAYER CORPORATION (US) 1996-05-28 — — US claimed
JP-9169749-A — — None — — JP disclosed
US-11851685-B2 Zwitterion buffer containing compositions and uses in electroanalytical devices and methods ROCHE DIABETES CARE, INC. (US) 2023-12-26 — — US disclosed
US-20220275348-A1 ZWITTERION BUFFER CONTAINING COMPOSITIONS AND USES IN ELECTROANALYTICAL DEVICES AND METHODS ROCHE DIABETES CARE, INC. 2022-09-01 — — US disclosed
EP-3388824-B1 METHODS OF DETECTING HIGH ANTIOXIDANT LEVELS DURING ELECTROCHEMICAL MEASUREMENTS AND FAILSAFING AN ANALYTE CONCENTRATION THEREFROM AS WELL AS DEVICES AND SYSTEMS INCORPORTING THE SAME ROCHE DIABETES CARE GMBH (DE) 2021-04-14 — — EP disclosed
US-20190264181-A1 ZWITTERION BUFFER CONTAINING COMPOSITIONS AND USES IN ELECTROANALYTICAL DEVICES AND METHODS ROCHE DIAGNOSTICS OPERATIONS, INC. 2019-08-29 — — US disclosed
US-7163616-B2 Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes BAYER CORPORATION (US) 2007-01-16 — — US disclosed
US-20030094384-A1 Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes ASCENSIA DIABETES CARE HOLDINGS AG (CH) 2003-05-22 — — US disclosed
EP-1293574-A2 Reagents, methods and devices for detecting analytes Bayer Corporation (US) 2003-03-19 — — EP disclosed
JP-H09169749-A PRODUCTION OF SUBSTITUTED 3-(PHENYLIMINO)-3H-PHENOTHIAZINES AND PHENOXAZINES BAYER CORP 1997-06-30 — — JP disclosed
EP-0775699-A1 Method for the preparation of substituted 3-(phenylimino)-3H-phenothiazines and phenoxazines Bayer Corporation (US) 1997-05-28 — — EP disclosed
US-5631371-A Method for the preparation of substituted 3-(phenylimino)-3H-phenothiazines and phenoxazines BAYER CORPORATION (US) 1997-05-20 — — US disclosed
Send feedback